|
|||||
|
|
Efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized,double-blind,phase 3 trial |
|
| Authors: | Kohei Kaku PhD Hiroyuki Isaka MS Taishi Sakatani MS Junko Toyoshima MS |
| Affiliation: | 1. Department of Medicine, Kawasaki Medical School, Okayama, Japan;2. Japan/Asia Clinical Development, Astellas Pharma Inc., Tokyo, Japan;3. Data Science, Astellas Pharma Inc., Tokyo, Japan;4. Clinical Pharmacology and Exploratory Development, Astellas Pharma Inc., Tokyo, Japan |
| Abstract: | |
| Keywords: | antidiabetic drug clinical trial insulin therapy phase III study SGLT2 inhibitor type 1 diabetes |